Epidemiology, diagnosis, and therapy of fungal infections in surgery

Infection Control and Hospital Epidemiology

Volumn 17, Issue 8, 1996, Pages 558-564

  Giamarellou, Helen ^a   Antoniadou, Anastasia ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

CANDIDIASIS; HUMAN; INFECTION CONTROL; MYCOSIS; REVIEW; RISK FACTOR; SEPSIS; SURGERY; SURGICAL INFECTION;

ANTIFUNGAL AGENTS; CANDIDIASIS; HUMANS; INFECTION CONTROL; MYCOSES; RISK FACTORS; SEPSIS; SURGICAL PROCEDURES, OPERATIVE; SURGICAL WOUND INFECTION;

EID: 0030203992     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141292     Document Type: Article

References (64)

1. Banerjee SN, Emori TG, Culver DH, the National Nosocomial Infections Surveillance System, et al. Secular trends in nosocomial primary bloodstream infections in the United States 1980-1990. Am J Med 1991;92(suppl 3B):86-89.
2. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526-1530.
3. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology risk factors and predictors of mortality. Clin Infect Dis 1992;15:414-421.
4. Komshian SV, Uwaydah AK, Sob JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patients: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-390.
5. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. Trends and sources of nosocomial fungaemia. Mycoses 1994;37:187-199.
6. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14(suppl 1):43-53.
7. Becker WK, Cioffiwg, McManus AT, et al. Fungal burn wound infection. Arch Surg 1991;126:44-48.
8. Gaines JD, Remington JS. Disseminated candidiasis in the surgical patient. Surgery 1972;72:730-736.
9. Edwards JE. Invasive Candida infections-evolution of a fungal pathogen. N Engl J Med 1991;324:1060-1062.
10. Buchard KW, Minor LB, Slotman GJ, Gann DS. Fungal sepsis in surgical patients. Arch Surg 1983;118:217-221.
11. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988;67:132-143.
12. Alden SM, Frank E, Flanchaum L. Abdominal candidiasis in surgical patients. Am Surg 1989;55:4549.
13. Castaldo P, Stratta RJ, Wood P, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991;126:149-156.
14. Kujath P. Fungal infections in surgical patients. Mycoses 1992;35:225-228.
15. Eubanks PJ, de Virgilio C, Klein S, Bongard F. Candida sepsis in surgical patients. Am J Surg 1993;166:617-620.
16. Vindenes H, Bjerknes R. The frequency of bacteremia and fungemia following wound cleaning and excision in patients with large burns. J Trauma 1993;35:742-749.
17. Cornwell E, Belzberg H, Berne TV, et al. The pattern of fungal infections in critically ill surgical patients. Am Surg 1995;61:847-850.
18. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995;20:1531-1534.
19. Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994;38:1422-1424.
20. Richet HM, Andremont A, Tanerede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991;13:211-215.
21. Miller PJ, Wenzel RP. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis 1987;156:471477.
22. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-2645.
23. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995;274:639-644.
24. Varquez JA, Sanchez V, Dmuchowski C, Dembry LM, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 1993;168:195-201.
25. Lee W, Burnie JP, Matthews RC, Oppenheim BO, Damani NN. Hospital outbreaks with yeasts. J Hosp Infect 1991;18(suppl A):237-249.
26. Pfaller MA. Epidemiology and control of fungal infections. Clin Infect Dis 1994;19(S1):8-13.
27. Pittet D, Monod F, Filthuth I, Frenk E, Suter PM, Auckenthaler R. Contour-clamped homogenous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med 1991;91(3B):256-263.
28. Rangel-Fausto MS, Martin MA, Saiman L, et al. High-Prevalence of Candida species on Hands of Health Care Workers (HCWs) in Surgical (S) and Neonatal (N) Intensive Care Units (ICUs): A Multicenter study. The 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; Orlando, FL; 1994. Abstract J 106.
29. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88-93.
30. Rantala A, Niinikoski J, Lehtonen OP. Pathogenesis of postoperative candidiasis: no detectable fungemia during reoperations after abdominal surgery. Mycoses 1990;34:47-52.
31. Ghannoum MA, Abu-Elteen KH. Pathogenicity determinants of Candida. Mycoses 1990;33:265-282.
32. Calderone RA. Host parasite relationships in candidiasis. Mycoses 1989;32(suppl 2):12-17.
33. Inone S, Wirman JA, Alexander JW, Trocki O, Cardel RR. Candida albicans translocation across the gut mucosa following burn injury. J Surg Res 1988;44:479-492.
34. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990;125:403-404.
35. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. Arch Intern Med 1989;149:2349-2353.
36. Bross J, Talbot GH, Maislin G, Hurqitz S, Strom BL. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989;87:614-620.
37. Slotman GJ, Shapiro E, Moffa SM. Fungal sepsis: multisite colonization versus fungemia. Am Surg 1994;60:107-113.
38. Pittet D, Monod M, Suter PM, Frenk G, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;6:751-758.
39. Thomson SR, Bade PG, Taams M, Chrystal V. Gastrointestinal mucormycosis. Br J Surg 1991;78:952-954.
40. Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ. Mucormycosis. Ann Intern Med 1980;93:93-108.
41. Editorial. Mucormycosis. Lancet 1986;1:1362-1363.
42. Hiatt JR, Kobayashi MR, Doty JE, Ramming KP. Acalculous Candida cholecystitis: a complication of critical surgical illness. Am Surg 1991;57:825-829.
43. Wiesenfeld HC, Berg SR, Sweet RL. Torulopsis glabrata pelvic abscess and fungemia. Obstet Gynecol 1994;83:887-889.
44. Pittet D, Anaissie E, Solomkin JS. When to start antifungal therapy in the non-neutropenic critically ill? In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Heidelberg, NY: Springer-Verlag Berlin Heidelberg Inc; 1996:567-577.
45. Edwards JEJ, Filler SG. Current strategies for treating invasive candidiasis: emphasis on infections in non-neutropenic patients. Clin Infect Dis 1992;I:14(S1):106-113.
46. Matthews RC, Burnie JP. New developments in the serological diagnosis of Candida infections. Mycoses 1983;31(suppl 2):34-38.
47. Jones JM. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 1990;3:3245.
48. McNeill MM, Gerber AR, McLaughlin DW, et al. Man antigenemia during invasive candidiasis caused by Candida tropicalis. Pediatr Infect Dis J 1992;II:493-496.
49. Reis E, Morrison CJ. Non culture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev 1993;6:311-323.
50. Makimura K, Murayama SY, Yamaguchi H. Detection of a wide range of medically important fungi by the polymerase chain reaction. J Med Microbiol 1994;40:358-364.
51. Burnic JP. Early diagnosis of systemic fungal infection. Curr Opin Infect Dis 1995;8:258-260.
52. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Nosocomial candidemia: characterization of the sequence of colonization and infection using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990;28:2732-2738.
53. Pfaller MA. Epidemiology of fungal infections. The promise of molecular typing. Clin Infect Dis 1995;20:1535-1539.
54. British Society for Antimicrobial Chemotherapy Working Party: management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 1994;20:522-528.
55. Solomkin JS. Pathogenesis and management of Candida infections syndromes in non-neutropenic patients. New Horiz 1993;1:202-213.
56. Anaissie E, Solomkin JS. Fungal infection - approach to the surgical patient at risk for candidiasis. In: Wilmore DW, Cheung LY, Harken AH, American College of Surgeons, eds. Scientific American Surgery. New York, NY: Scientific American, Inc; 1994:1-19.
57. Kujath P, Lerch K. New antimicrobial agents under clinical investigation. Secondary mycosis in surgery: treatment with fluconazole. Infection 1989;12:111-117.
58. Nolla-Salas J, Leon C, Torres-Rodriguez JM, Martin E, Sitges-Serra A Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clin Infect Dis 1992;14:952-954.
59. Graninger W, Presteril E, Schneeweis B, Teleky B, Georgopoulos A. Treatment of Candida albicans fungaemia with fluconazole. J Infect 1992;26:133-146.
60. Kujath P, Lerch K, Kochendorfer P, Boos C. Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 1993;21:28,376-334,382.
61. Nassoura Z, Ivatury RR, Simon RJ, Jabbour N, Stahl WM. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma 1993;35:290-294.
62. Anaissie EJ, Darwiche R, Mera J, Gentry L, Abi-Said D, Bodey GP. A prospective randomized multicenter study comparing fluconazole to amphotericin B for nosocomial candidiasis. The 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; New Orleans, LA; 1993. Abstract 289.
63. Rex JH, Bennett JE, Sugar AM, et al, for the Candidemia Study Group, the National Institute of Allergy and Infectious Diseases Mycoses Study Group. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-1330.
64. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995;39:1-8.